Comments for Pharmamotion

Comment on Ramipril and hydrochlorothiazide (Tritazide and related) indications, contraindications and posology updated in a review by the CHMP by Mechanism of action video animation: ACE inhibitors, Angiotensin II receptor blockers (ARBs) and the Renin Angiotensin Aldosterone System | Pharmamotion

Fri, 05 Mar 2010 02:51:00 +0000

[...] Ramipril (Altace, Tritace, Ramace, Ramiwin) [...]

Comment on Calcium channel blockers: classification, mechanism of action and indications by Geriatric pharmacology: pharmacokinetics, polypharmacy and related topics | Pharmamotion

Sat, 27 Feb 2010 16:44:43 +0000

[...] index (digoxin, phenytoin, warfarin, theophylline, lithium) cardiovascular (antihypertensives, calcium channel blockers, propanolol, diuretics – see indications and mechanism of action- ), psychotropics (TCAs, [...]

Comment on Agomelatine (Valdoxan) for major depressive episodes by Serotonin (5-HT): receptors, agonists and antagonists | Pharmamotion

Serotonin (5-HT): receptors, agonists and antagonists | Pharmamotion — Sat, 27 Feb 2010 16:36:56 +0000

[...] Agomelatine is a new antidepressant with agonist action at the melatonin receptor and antagonism at the 5-HT2C receptor. [...]

Comment on FDA video warning on metoclopramide and tardive dyskinesia by PowerPoint presentations: antipsychotics (neuroleptics) pharmacology | Pharmamotion

Sat, 27 Feb 2010 16:22:27 +0000

[...] Tardive Dyskinesia. [...]

Comment on Overview on monoclonal antibody therapy: PPT, images and videos by Antiplatelet agents: mechanisms of action and general overview | Pharmamotion

Sat, 27 Feb 2010 04:54:48 +0000

[...] is a chimeric human-murine monoclonal antibody directed against GPIIb/IIIa, current indications include unstable angina that does not respond to [...]

Comment on Video on aspirin pharmacokinetics: the role of the ion trapping phenomenon by Antiplatelet agents: mechanisms of action and general overview | Pharmamotion

Sat, 27 Feb 2010 04:54:32 +0000

[...] Aspirin is indicated as prophylaxis against transient ischemic attacks, myocardial infarction and thromboembolic disorders. It is also used for the treatment of acute coronary syndromes and in the prevention of reoclusion in coronary revascularization procedures. Since side effects such as GI bleeding and acute renal insufficiency are dose dependent, the recommended antiplatelet dose ranges from 75 mg to 325 mg. A related post in this blog reviews some relevant aspects about aspirin pharmacokinetics. [...]

Comment on Video: molecular mechanisms of nicotine addiction by Flavio Guzmán, MD

Flavio Guzmán, MD — Mon, 15 Feb 2010 05:49:41 +0000

The video is working, you can try an add on for Firefox that allows you to download YouTube videos.

Comment on Animation explaining mechanism of action of glucocorticoids and comparative glucocorticoids potencies table. by Mecanismo de acción de los glucocorticoides | Farmacología y Medicina

Mecanismo de acción de los glucocorticoides | Farmacología y Medicina — Wed, 10 Feb 2010 23:59:20 +0000

[...] Mechanism of action of glucocorticoids [...]

Comment on Mechanism of action video animation: ACE inhibitors, Angiotensin II receptor blockers (ARBs) and the Renin Angiotensin Aldosterone System by moeen

moeen — Tue, 09 Feb 2010 15:34:18 +0000

ACE inhibitors are contraindicated in patients with: Previous angioedema associated with ACE inhibitor therapy Renal artery stenosis (bilateral, or unilateral with a solitary functioning kidney)

how i want to know

Comment on Video: molecular mechanisms of nicotine addiction by Huzaimah

Huzaimah — Wed, 03 Feb 2010 03:07:23 +0000

Dear Writer,

I couldn’t see this video, its not working..Can I for the copy of it? Mechanism of nicotine addiction.